Abortion Safety and Use with Normally Prescribed Mifepristone in Canada.
Laura SchummersElizabeth K DarlingSheila DunnKimberlyn McGrailAnastasia GayowskyMichael R LawTracey-Lea LabaJanusz KaczorowskiWendy V NormanPublished in: The New England journal of medicine (2021)
After mifepristone became available as a normal prescription, the abortion rate remained relatively stable, the proportion of abortions provided by medication increased rapidly, and adverse events and complications remained stable, as compared with the period when mifepristone was unavailable. (Funded by the Canadian Institutes of Health Research and the Women's Health Research Institute.).